Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Curiel

Showing results (241-250 of 255) with videos related to

Pageof 26
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expressionA Hemminki, N Belousova, K R Zinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Polynucleotide immunization of nonhuman primates against carcinoembryonic antigenR M Conry, S A White, P N Fultz, et al.
Cancer Research|June 11, 1999
Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in miceD L Gu, A M Gonzalez, M A Printz, et al.
Nature Medicine|December 1, 2001
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cellsW Zou, V Machelon, A Coulomb-L'Hermin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivoP N Reynolds, K R Zinn, V D Gavrilyuk, et al.
Gene Therapy|March 19, 2004
Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoterZ B Zhu, S K Makhija, B Lu, et al.
Arthritis and Rheumatism|October 15, 2003
Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritisR L Smeets, F A J van de Loo, L A B Joosten, et al.
The Journal of Gene Medicine|September 11, 2002
Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcomaM A Witlox, V W Van Beusechem, J Grill, et al.
Gene Therapy|July 22, 2005
A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapyM A Stoff-Khalili, A A Rivera, J N Glasgow, et al.
Cancer Research|April 18, 2001
Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cellsT P Cripe, E J Dunphy, A D Holub, et al.
Pageof 26

Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expressionA Hemminki, N Belousova, K R Zinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Polynucleotide immunization of nonhuman primates against carcinoembryonic antigenR M Conry, S A White, P N Fultz, et al.
Cancer Research|June 11, 1999
Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in miceD L Gu, A M Gonzalez, M A Printz, et al.
Nature Medicine|December 1, 2001
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cellsW Zou, V Machelon, A Coulomb-L'Hermin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivoP N Reynolds, K R Zinn, V D Gavrilyuk, et al.
Gene Therapy|March 19, 2004
Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoterZ B Zhu, S K Makhija, B Lu, et al.
Arthritis and Rheumatism|October 15, 2003
Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritisR L Smeets, F A J van de Loo, L A B Joosten, et al.
The Journal of Gene Medicine|September 11, 2002
Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcomaM A Witlox, V W Van Beusechem, J Grill, et al.
Gene Therapy|July 22, 2005
A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapyM A Stoff-Khalili, A A Rivera, J N Glasgow, et al.
Cancer Research|April 18, 2001
Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cellsT P Cripe, E J Dunphy, A D Holub, et al.
Pageof 26